Transdermal delivery of dehydroepiandrosterone

Details Transdermal delivery of dehydroepiandrosterone Transdermal delivery of dehydroepiandrosterone

1996-08-02

1998-01-20

Phelan, D. Gabrielle

Drug, bio-affecting and body treating compositions

Preparations characterized by special physical form

Web, sheet or filament bases; compositions of bandages; or...

424447, 514944, 514969, A61F 1300

Patent

active

057098786

ABSTRACT:
Disclosed is a novel transdermal delivery system for dehydroepiandrosterone (DHEA). Using phospholipids as vehicles, DHEA can be administered into and through the skin when topically applied. Numerous advantages apply to this modality of therapy.

REFERENCES:
patent: 4340594 (1982-07-01), Mizushima
patent: 4780455 (1988-10-01), Lieberman
patent: 4783450 (1988-11-01), Fawzi et al.
patent: 4892737 (1990-01-01), Bodor et al.
patent: 4906463 (1990-03-01), Cleary et al.
patent: 4978532 (1990-12-01), El-Rashidy
patent: 5008111 (1991-04-01), Bodor
patent: 5075113 (1991-12-01), DuBois
patent: 5204119 (1993-04-01), Shiobar et al.
patent: 5206008 (1993-04-01), Loria
patent: 5231090 (1993-07-01), Hsia et al.
patent: 5314906 (1994-05-01), Bombardelli
patent: 5332576 (1994-07-01), Mantelle
patent: 5484833 (1996-01-01), Bombardelli
patent: 5518730 (1996-05-01), Fuisz

Affiliated with

Also associated with

Rating

Transdermal delivery of dehydroepiandrosterone does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Transdermal delivery of dehydroepiandrosterone, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Transdermal delivery of dehydroepiandrosterone will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-723501